• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西环素干扰寨卡病毒丝氨酸蛋白酶并抑制人皮肤成纤维细胞中的病毒复制。

Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.

机构信息

Bioinformatics Programme, Institute of Biological Sciences, Faculty of Science, Kuala Lumpur 50603, Malaysia.

Department of Anatomy, College of Medicine, University of Babylon, Babylon, Iraq.

出版信息

Molecules. 2021 Jul 16;26(14):4321. doi: 10.3390/molecules26144321.

DOI:10.3390/molecules26144321
PMID:34299596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8306286/
Abstract

Zika virus (ZIKV) represents a re-emerging threat to global health due to its association with congenital birth defects. ZIKV NS2B-NS3 protease is crucial for virus replication by cleaving viral polyprotein at various junctions to release viral proteins and cause cytotoxic effects in ZIKV-infected cells. This study characterized the inhibitory effects of doxycycline against ZIKV NS2B-NS3 protease and viral replication in human skin cells. The in silico data showed that doxycycline binds to the active site of ZIKV protease at a low docking energy (-7.8 Kcal/mol) via four hydrogen bonds with the protease residues TYR1130, SER1135, GLY1151, and ASP83. Doxycycline efficiently inhibited viral NS2B-NS3 protease at average human temperature (37 °C) and human temperature with a high fever during virus infection (40 °C). Interestingly, doxycycline showed a higher inhibitory effect at 40 °C (IC50 = 5.3 µM) compared to 37 °C (9.9 µM). The virus replication was considerably reduced by increasing the concentration of doxycycline. An approximately 50% reduction in virus replication was observed at 20 µM of doxycycline. Treatment with 20 µM of doxycycline reduced the cytopathic effects (CPE), and the 40 µM of doxycycline almost eliminated the CPE of human skin cells. This study showed that doxycycline binds to the ZIKV protease and inhibits its catalytic activity at a low micro-molecular concentration range. Treatment of human skin fibroblast with doxycycline eliminated ZIKV infection and protected the cells against the cytopathic effects of the infection.

摘要

寨卡病毒(ZIKV)因其与先天性出生缺陷有关,对全球健康构成了新的威胁。ZIKV NS2B-NS3 蛋白酶对于病毒复制至关重要,它通过在不同的连接处切割病毒多蛋白,释放病毒蛋白,并在 ZIKV 感染的细胞中引起细胞毒性作用。本研究旨在表征强力霉素对 ZIKV NS2B-NS3 蛋白酶和人皮肤细胞中病毒复制的抑制作用。计算数据表明,强力霉素通过与蛋白酶残基 TYR1130、SER1135、GLY1151 和 ASP83 形成四个氢键,以低对接能(-7.8 Kcal/mol)结合到 ZIKV 蛋白酶的活性部位。强力霉素在平均人体温度(37°C)和病毒感染时的人体高温(40°C)下,有效地抑制病毒 NS2B-NS3 蛋白酶。有趣的是,强力霉素在 40°C 时的抑制效果更高(IC50=5.3 µM),而在 37°C 时的抑制效果较低(9.9 µM)。随着强力霉素浓度的增加,病毒复制明显减少。当强力霉素的浓度增加到 20 µM 时,病毒复制减少了约 50%。用 20 µM 的强力霉素处理可减少细胞病变效应(CPE),而 40 µM 的强力霉素几乎消除了人皮肤细胞的 CPE。本研究表明,强力霉素与 ZIKV 蛋白酶结合,并在低微摩尔浓度范围内抑制其催化活性。用强力霉素处理人皮肤成纤维细胞可消除 ZIKV 感染,并保护细胞免受感染的细胞病变效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/b68ea509895c/molecules-26-04321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/8c112869bee5/molecules-26-04321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/c91a9741dd6a/molecules-26-04321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/b68ea509895c/molecules-26-04321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/8c112869bee5/molecules-26-04321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/c91a9741dd6a/molecules-26-04321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a12b/8306286/b68ea509895c/molecules-26-04321-g003.jpg

相似文献

1
Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.多西环素干扰寨卡病毒丝氨酸蛋白酶并抑制人皮肤成纤维细胞中的病毒复制。
Molecules. 2021 Jul 16;26(14):4321. doi: 10.3390/molecules26144321.
2
Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.寨卡 NS2B 是一个关键因素,招募 NS3 到内质网并激活其蛋白酶活性。
Virus Res. 2020 Jan 2;275:197793. doi: 10.1016/j.virusres.2019.197793. Epub 2019 Oct 29.
3
Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.开发一种可抑制寨卡病毒复制的 NS2B-NS3 蛋白酶抑制剂。
Virus Res. 2023 May;329:199092. doi: 10.1016/j.virusres.2023.199092. Epub 2023 Apr 5.
4
Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.黄酮类双功能抑制剂抗寨卡病毒感染的构效关系。
Biochem Pharmacol. 2020 Jul;177:113962. doi: 10.1016/j.bcp.2020.113962. Epub 2020 Apr 6.
5
The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection.GA-Hecate 肽在不同步骤抑制 ZIKV 复制周期,并能在细胞感染后抑制黄病毒 NS2B-NS3 蛋白酶。
Protein Pept Lett. 2024;31(7):532-543. doi: 10.2174/0109298665308871240703090408.
6
Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.寨卡病毒双组分NS2B-NS3蛋白酶的特性及变构小分子拮抗剂的结构辅助鉴定
Antiviral Res. 2017 Jul;143:218-229. doi: 10.1016/j.antiviral.2017.04.015. Epub 2017 Apr 29.
7
MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.MD 模拟揭示寨卡病毒 NS2B/NS3 蛋白酶中氧阴离子口袋的交替构象。
Proteins. 2020 Feb;88(2):345-354. doi: 10.1002/prot.25809. Epub 2019 Sep 9.
8
Zika Virus NS2A-Mediated Virion Assembly.寨卡病毒 NS2A 介导的病毒粒子组装。
mBio. 2019 Oct 29;10(5):e02375-19. doi: 10.1128/mBio.02375-19.
9
NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.NS2B-NS3 蛋白酶抑制剂作为开发抗寨卡病毒抗病毒药物的有前途的化合物:系统评价。
J Med Virol. 2022 Feb;94(2):442-453. doi: 10.1002/jmv.27386. Epub 2021 Oct 20.
10
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.现有药物通过靶向NS2B-NS3相互作用作为寨卡病毒的广谱强效抑制剂。
Cell Res. 2017 Aug;27(8):1046-1064. doi: 10.1038/cr.2017.88. Epub 2017 Jul 7.

引用本文的文献

1
Novel and repurposed antiviral molecules for arbovirus infections with epidemic Potential: A systematic review.用于具有流行潜力的虫媒病毒感染的新型及重新利用的抗病毒分子:一项系统综述。
New Microbes New Infect. 2025 Jul 10;66:101614. doi: 10.1016/j.nmni.2025.101614. eCollection 2025 Aug.
2
Repositioning of Antibiotics in the Treatment of Viral Infections.抗生素在病毒感染治疗中的再定位。
Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7.
3
Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.

本文引用的文献

1
Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope.评估与基孔肯雅病毒包膜 E2EP3 肽表位融合的木瓜花叶病毒纳米颗粒产生的中和抗体。
Trop Biomed. 2021 Mar 1;38(1):36-41. doi: 10.47665/tb.38.1.007.
2
Antiviral and virucidal activities of sulphated polysaccharides against Japanese encephalitis virus.硫酸多糖对日本脑炎病毒的抗病毒和杀病毒活性。
Trop Biomed. 2020 Sep 1;37(3):713-721. doi: 10.47665/tb.37.3.713.
3
Role of Endoplasmic Reticulum-Associated Proteins in Flavivirus Replication and Assembly Complexes.
在临床试验中靶向 NS2B-NS3 的正交黄病毒抑制剂,通过竞争性蛋白酶抑制的临床前体内疗效和细胞抗病毒活性。
Molecules. 2024 Aug 27;29(17):4047. doi: 10.3390/molecules29174047.
4
Recent advances in the study of zika virus structure, drug targets, and inhibitors.寨卡病毒结构、药物靶点及抑制剂研究的最新进展
Front Pharmacol. 2024 Jul 1;15:1418516. doi: 10.3389/fphar.2024.1418516. eCollection 2024.
5
Ivermectin Inhibits the Replication of Usutu Virus In Vitro.伊维菌素抑制乌苏图病毒在体外的复制。
Viruses. 2022 Jul 27;14(8):1641. doi: 10.3390/v14081641.
6
A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika.关于应用结构基因组学方法对抗三种媒介传播病毒性疾病(登革热、基孔肯雅热和寨卡病毒病)进行药物研发的综述。
Virus Genes. 2022 Jun;58(3):151-171. doi: 10.1007/s11262-022-01898-5. Epub 2022 Apr 8.
7
The Anticancer Potential of Doxycycline and Minocycline-A Comparative Study on Amelanotic Melanoma Cell Lines.强力霉素和米诺环素的抗癌潜力——对无色素黑色素瘤细胞系的比较研究。
Int J Mol Sci. 2022 Jan 13;23(2):831. doi: 10.3390/ijms23020831.
内质网相关蛋白在黄病毒复制与装配复合体中的作用
Pathogens. 2019 Sep 12;8(3):148. doi: 10.3390/pathogens8030148.
4
Zika Virus Protease Cleavage of Host Protein Septin-2 Mediates Mitotic Defects in Neural Progenitors.寨卡病毒蛋白酶对宿主蛋白 Septin-2 的切割作用介导了神经前体细胞有丝分裂缺陷。
Neuron. 2019 Mar 20;101(6):1089-1098.e4. doi: 10.1016/j.neuron.2019.01.010. Epub 2019 Jan 31.
5
Current concerns and perspectives on Zika virus co-infection with arboviruses and HIV.寨卡病毒与虫媒病毒和 HIV 合并感染的当前关注和观点。
J Autoimmun. 2018 May;89:11-20. doi: 10.1016/j.jaut.2018.01.002. Epub 2018 Jan 17.
6
Molecular cloning and characterization of the genes encoding the proteins of Zika virus.寨卡病毒蛋白质编码基因的分子克隆与特性分析
Gene. 2017 Sep 10;628:117-128. doi: 10.1016/j.gene.2017.07.049. Epub 2017 Jul 15.
7
Zika Virus.寨卡病毒
N Engl J Med. 2016 Jul 21;375(3):294-5. doi: 10.1056/NEJMc1606769. Epub 2016 Jun 29.
8
Pharmacodynamics of aminoglycosides and tetracycline derivatives against Japanese encephalitis virus.氨基糖苷类和四环素衍生物对日本脑炎病毒的药效学
Asian Pac J Trop Med. 2016 Mar;9(3):241-6. doi: 10.1016/j.apjtm.2016.01.033. Epub 2016 Jan 13.
9
Antiviral activity of doxycycline against vesicular stomatitis virus in vitro.强力霉素在体外对水疱性口炎病毒的抗病毒活性。
FEMS Microbiol Lett. 2015 Nov;362(22). doi: 10.1093/femsle/fnv195. Epub 2015 Oct 12.
10
Biology of Zika Virus Infection in Human Skin Cells.寨卡病毒在人类皮肤细胞中的感染生物学
J Virol. 2015 Sep;89(17):8880-96. doi: 10.1128/JVI.00354-15. Epub 2015 Jun 17.